Almac Group is a global pharmaceutical company headquartered in the UK and Ireland, offering end-to-end drug development and manufacturing solutions. The company specializes in API development and manufacturing across small molecules, HPAPIs, peptides, and radiolabeling, supported by expertise in custom and flow chemistry, analytical services, and solid-state chemistry. Almac also provides oligonucleotide synthesis and RNA biomarker development with dedicated UK facilities, alongside clinical- and commercial-scale pharmaceutical manufacturing.